| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adenocarcinoma of the lung presenting as a diffuse interstitial process in a 25-year-old man
|
Mapel, Douglas W.
|
|
1996
|
15 |
2 |
p. 239-244
6 p.
|
artikel
|
| 2 |
Adenoviral mediated gene transfer: Effectivestrategy to reduce tumor burdenin an immunocompetent model of pleural based mesothelioma
|
Kucharczuk, J.
|
|
1996
|
15 |
2 |
p. 275-276
2 p.
|
artikel
|
| 3 |
Adenovirus-mediated gene therapy for malignant mesothelioma: A comparison of immunosuppressed, immunodeficient and immunocompetent tumor models
|
Elshami, A.A.
|
|
1996
|
15 |
2 |
p. 274-
1 p.
|
artikel
|
| 4 |
AMAD-2 and HBME-1. Evaluation of their immuno-reactivity with malignant mesothelioma
|
Donna, A.
|
|
1996
|
15 |
2 |
p. 267-268
2 p.
|
artikel
|
| 5 |
Amurine model of mesothelioma-pathology, immunology and biology
|
Bielefeldt-Ohmann, H
|
|
1996
|
15 |
2 |
p. 264-
1 p.
|
artikel
|
| 6 |
Antisense oligonucleotides specific for transforming growth factor-beta (TGF-β) inhibit the growth of malignant mesothelioma (MM) both in vitro and in vivo
|
Marzo, AL
|
|
1996
|
15 |
2 |
p. 276-
1 p.
|
artikel
|
| 7 |
Apatient-like human malignant pleural mesothelioma nude-mouse model
|
Astoul, Ph.
|
|
1996
|
15 |
2 |
p. 267-
1 p.
|
artikel
|
| 8 |
A phase I II trial of etoposide and cisplatin in extensive small cell lung cancer: A cancer and Leukemia Group B study
|
Mitchell, Edith P.
|
|
1996
|
15 |
2 |
p. 215-223
9 p.
|
artikel
|
| 9 |
A possible role for p16INK4 in malignant mesothelioma
|
Prins, J.-B.
|
|
1996
|
15 |
2 |
p. 262-263
2 p.
|
artikel
|
| 10 |
Brain relapses in chemotherapy-treated small cell lung cancer: a retrospective review of two time-dose regimens of therapeutic brain irradiation
|
Bach, Flemming
|
|
1996
|
15 |
2 |
p. 171-181
11 p.
|
artikel
|
| 11 |
B7-1 transfection can abrogate tumor non-immunogenicity but in vivo tumor outgrowth occurs via a decay in ctlactivity
|
Leong, CC
|
|
1996
|
15 |
2 |
p. 265-
1 p.
|
artikel
|
| 12 |
CD44, hyaluronan, and human mesotheliomas
|
Penno, M.B.
|
|
1996
|
15 |
2 |
p. 268-
1 p.
|
artikel
|
| 13 |
Clinical problems with the early diagnosis of malignant mesothelioma
|
Ekholdt, PF
|
|
1996
|
15 |
2 |
p. 274-
1 p.
|
artikel
|
| 14 |
Coexpression of allogeneic MHC and a costimulatory molecule (B7-1) augments the immune response to a mesothelioma cell line
|
Marley, JV
|
|
1996
|
15 |
2 |
p. 265-266
2 p.
|
artikel
|
| 15 |
Combined systemic CDDP-interferon alpha (IFNα) in advanced pleural malignant mesothelioma (MM)
|
Soulié, P.
|
|
1996
|
15 |
2 |
p. 278-
1 p.
|
artikel
|
| 16 |
Combined treatment in malignant mesothelioma: Personal experience
|
Mezzetti, Maurizio
|
|
1996
|
15 |
2 |
p. 276-277
2 p.
|
artikel
|
| 17 |
Comparative genomic hybridization and its application to malignant pleural mesothelioma
|
Bjorkqvist, A-M.
|
|
1996
|
15 |
2 |
p. 259-
1 p.
|
artikel
|
| 18 |
Comparison of chronic inhalation toxicity of refractory ceramic fibers in rats and hamsters
|
Hesterberg, T.W.
|
|
1996
|
15 |
2 |
p. 261-
1 p.
|
artikel
|
| 19 |
Comparison of mortality from malignant mesothelioma in 34 countries
|
de Klerk, NH
|
|
1996
|
15 |
2 |
p. 272-
1 p.
|
artikel
|
| 20 |
Comparison of three different staging system in evaluation of prognosis in malignant pleural mesothelioma
|
Tammilehto, L.
|
|
1996
|
15 |
2 |
p. 279-
1 p.
|
artikel
|
| 21 |
Detection of SSCP patterns for WT-1 gene in malignant mesothelioma
|
Kumar Singh, S.
|
|
1996
|
15 |
2 |
p. 263-
1 p.
|
artikel
|
| 22 |
Development of gene therapy for mesothelioma using the Herpes simplex thymidine kinase suicide gene system
|
Touraine, Renaud L
|
|
1996
|
15 |
2 |
p. 279-
1 p.
|
artikel
|
| 23 |
Differential pleural fluid kinetics in msothelioma and carcinoma in man - a study using a dual-isotope technique
|
Basran, G.S.
|
|
1996
|
15 |
2 |
p. 267-
1 p.
|
artikel
|
| 24 |
Early alterations by asbestos of the rat pleural mesothelial cell integrity
|
Jaurand, MC
|
|
1996
|
15 |
2 |
p. 261-
1 p.
|
artikel
|
| 25 |
Environmental exposure to crocidolite and mesotheliom: Exposure-response relationships
|
Hansen, J
|
|
1996
|
15 |
2 |
p. 271-
1 p.
|
artikel
|
| 26 |
Estimation of the pleural mesothelioma incidence in France based on the death certificates and the data of a case-control study
|
P, Brochard
|
|
1996
|
15 |
2 |
p. 270-
1 p.
|
artikel
|
| 27 |
European multicentric case control study on non-occupational (domestic and environmental) exposure to asbestos and pleural mesothelioma
|
Magnani, C.
|
|
1996
|
15 |
2 |
p. 272-
1 p.
|
artikel
|
| 28 |
Evaluation of asbestos exposure in pleural mesothelioma using quantification of asbestos bodies in bronchoalveolar lavage fluid or lung tissue
|
Pairon, JC
|
|
1996
|
15 |
2 |
p. 273-
1 p.
|
artikel
|
| 29 |
Exposure to asbestos and malignant mesothelioma in Western Australia
|
de Klerk, NH
|
|
1996
|
15 |
2 |
p. 271-272
2 p.
|
artikel
|
| 30 |
Expression and organization of fibronectin and thrombospondin by pleural mesothelial cells and asbestos-induced mesothelioma cells
|
Ferriola, P.C.
|
|
1996
|
15 |
2 |
p. 260-
1 p.
|
artikel
|
| 31 |
Gene transfer into mesothelioma cells using adenovirus vector
|
Cordier, L.
|
|
1996
|
15 |
2 |
p. 274-
1 p.
|
artikel
|
| 32 |
Glutathione-S-transferase expression in malignant mesothelioma and non neoplastic mesothelium: An immunohistochemical study
|
Segers, K.
|
|
1996
|
15 |
2 |
p. 269-
1 p.
|
artikel
|
| 33 |
Growth of amurinemalignant mesothelioma cell line in vivo. Lack of immune aggression due to immune deviation
|
Caminschi, I
|
|
1996
|
15 |
2 |
p. 264-265
2 p.
|
artikel
|
| 34 |
Histopathological grading of response to induction chemotherapy in non-small cell lung cancer: a preliminary study
|
Milano, Salvatore
|
|
1996
|
15 |
2 |
p. 183-187
5 p.
|
artikel
|
| 35 |
IASLC Announcement
|
|
|
1996
|
15 |
2 |
p. 281-
1 p.
|
artikel
|
| 36 |
IASLC Calendar
|
|
|
1996
|
15 |
2 |
p. 257-258
2 p.
|
artikel
|
| 37 |
IGF1 receptor antisence gene therapy in mesothelioma
|
Mew, Daphne
|
|
1996
|
15 |
2 |
p. 276-
1 p.
|
artikel
|
| 38 |
IL6, TNF-ALFA and IL1-beta as biochemical markers of malignant pleural effusion (PE) in mesothelioma (DMM): Correlation with releasing properties of human mesothelial cells (HMC) and DMM cells (DMMC)
|
Mutti, L.
|
|
1996
|
15 |
2 |
p. 266-
1 p.
|
artikel
|
| 39 |
Immunohistochemical differences between hyaluronan and non-hyaluronan producing malignant mesothelioma
|
Thylen, A
|
|
1996
|
15 |
2 |
p. 269-
1 p.
|
artikel
|
| 40 |
Increased frequency of parental cancer among cases of malignant pleural mesothelioma: A case-control study
|
Huncharek, M.
|
|
1996
|
15 |
2 |
p. 271-
1 p.
|
artikel
|
| 41 |
Individual susceptibility to malignant mesothelioma
|
Pelin, K.
|
|
1996
|
15 |
2 |
p. 262-
1 p.
|
artikel
|
| 42 |
Induction of apoptosis and stabilization of P53 protein in normal rat pleural mesothelial cells treated, in vitro, with asbestos fibres
|
Levresse, V
|
|
1996
|
15 |
2 |
p. 262-
1 p.
|
artikel
|
| 43 |
INF-γ induced modification of cell cycle in human mesothelioma cell lines (HMCL)
|
Vivo, C.
|
|
1996
|
15 |
2 |
p. 263-264
2 p.
|
artikel
|
| 44 |
Inflammation in malignant pleural mesothelioma: Interleukin-6 (IL-6) and its relationship to serum parameters
|
Nakano, T.
|
|
1996
|
15 |
2 |
p. 266-
1 p.
|
artikel
|
| 45 |
Interferon alpha-2a and combined chemotherapy as first line treatment in SCLC patients: a randomised trial
|
Zarogoulidis, K.
|
|
1996
|
15 |
2 |
p. 197-205
9 p.
|
artikel
|
| 46 |
Intracavitary and systemic rIL-2 in the treatment of malignant mesothelioma of the pleura
|
Castagneto, B.
|
|
1996
|
15 |
2 |
p. 265-
1 p.
|
artikel
|
| 47 |
Intracellular diacylglycerol: a mitogenic second messenger proposable as marker of transformation in squamous cell carcinoma of the lung
|
Casamassima, Franco
|
|
1996
|
15 |
2 |
p. 161-170
10 p.
|
artikel
|
| 48 |
Intralesional cytokine therapy in cancer a phase 1 and 2 study of alpha interferon and GM-CSF infusion in mesothelioma
|
Davidson, J.A.
|
|
1996
|
15 |
2 |
p. 265-
1 p.
|
artikel
|
| 49 |
Intra operative photodynamic therapy following resection for mesothelioma: Clinical and experimental approach
|
Ris, H.B.
|
|
1996
|
15 |
2 |
p. 277-
1 p.
|
artikel
|
| 50 |
In vitro and in vivo effect of taxol on mesothelioma murine and human cell lines and investigation of cremophoreffect on mesothelioma's sensitivity to adriamycin
|
Davidson, JA
|
|
1996
|
15 |
2 |
p. 274-
1 p.
|
artikel
|
| 51 |
Is thrombomodulin useful as a tumor marker of a lung cancer?
|
Tamura, Atsuhisa
|
|
1996
|
15 |
2 |
p. 189-195
7 p.
|
artikel
|
| 52 |
Large T-antigen and wild-type P53 relationships in pleural mesothelioma
|
Carbone, M.
|
|
1996
|
15 |
2 |
p. 259-
1 p.
|
artikel
|
| 53 |
Lung squamous cell carcinoma presenting with brain metastases in an HIV-positive patient
|
Kosmopoulou, O.
|
|
1996
|
15 |
2 |
p. 245-249
5 p.
|
artikel
|
| 54 |
Malignant mesothelioma in Australia 1982–1995
|
Leigh, J.
|
|
1996
|
15 |
2 |
p. 272-
1 p.
|
artikel
|
| 55 |
Malignant mesothelioma in women: Clinical-pathologic correlation and mineral fiber analysis
|
Roggli, V.L.
|
|
1996
|
15 |
2 |
p. 269-
1 p.
|
artikel
|
| 56 |
Malignant mesothelioma of the pleura in Trieste-Monfalcone area, Italy
|
Bianchi, C.
|
|
1996
|
15 |
2 |
p. 270-
1 p.
|
artikel
|
| 57 |
Meeting report
|
|
|
1996
|
15 |
2 |
p. 251-256
6 p.
|
artikel
|
| 58 |
Mesothelioma and othermalignancies due to erionite exposure in Turkey
|
Çöplü, L
|
|
1996
|
15 |
2 |
p. 270-
1 p.
|
artikel
|
| 59 |
Mesothelioma prevention for high risk subjects previously exposed to crocidolite at wittenoom, Western Australia
|
Musk, AW
|
|
1996
|
15 |
2 |
p. 273-
1 p.
|
artikel
|
| 60 |
Mineral fibre content of lungs in mesothelioma cases seeking compensation in quebec
|
Dufresne, A.
|
|
1996
|
15 |
2 |
p. 270-271
2 p.
|
artikel
|
| 61 |
Mitochondrial superoxide dismutase in human mesothelial cells and mesothelioma cell lines
|
Kinnula, V.L.
|
|
1996
|
15 |
2 |
p. 261-
1 p.
|
artikel
|
| 62 |
Multiple signalling pathways and transcription factors lead to protooncogene induction by crocidolite asbestos in rat pleural mesothelial (RPM) cells
|
Mossman, B.T.
|
|
1996
|
15 |
2 |
p. 262-
1 p.
|
artikel
|
| 63 |
New imaging modalities of mesothelioma (CT versus MRI)
|
Giron, J.
|
|
1996
|
15 |
2 |
p. 275-
1 p.
|
artikel
|
| 64 |
Pastexposure to asbestos and pleural mesothelioma: Dose-response relalionship
|
Iwatsubo, Y
|
|
1996
|
15 |
2 |
p. 271-
1 p.
|
artikel
|
| 65 |
p53 gene transfer in human malignant mesothelioma (MM) cells
|
Procopio, A.
|
|
1996
|
15 |
2 |
p. 277-
1 p.
|
artikel
|
| 66 |
Pharmacokinetic studies on cisplatin (CDDP) and irinotecan hydrochloride (CPT-11) administered intravenously in patients with unresectable malignant pleural mesothelioma
|
Shinjyo, M.
|
|
1996
|
15 |
2 |
p. 277-
1 p.
|
artikel
|
| 67 |
Pharmacokinetic studies on cisplatin (CDDP) and irinotecan hydrochloride (CPT-11) administered intravenously in patients with unresectable malignant pleural mesothelioma
|
Shinjyo, M.
|
|
1996
|
15 |
2 |
p. 277-278
2 p.
|
artikel
|
| 68 |
Phase I/II study of combination chemotherapy with cisplatin, carboplatin and etoposide in small cell lung cancer
|
Sakurai, Masanori
|
|
1996
|
15 |
2 |
p. 225-232
8 p.
|
artikel
|
| 69 |
Plasma and pleural fluid analysis of fibrinolytic system in malignant pleural mesothelioma
|
Emril, S.
|
|
1996
|
15 |
2 |
p. 268-
1 p.
|
artikel
|
| 70 |
Platelet derived growth factor (PDGF) is a chemoattractant for human malignant mesothelioma cells
|
Klominek, J.
|
|
1996
|
15 |
2 |
p. 261-262
2 p.
|
artikel
|
| 71 |
Pleural mesothelial cells recognize and internalize serum-coated crocidolite asbestos via a vitronectin receptor, αvβ5
|
Boylan, AM
|
|
1996
|
15 |
2 |
p. 259-
1 p.
|
artikel
|
| 72 |
Pleural mesothelioma and environmental asbestos pollution around an asbestos-cement factory in Italy
|
Magnani, C
|
|
1996
|
15 |
2 |
p. 273-
1 p.
|
artikel
|
| 73 |
Pulmonary blastoma: a rare lung malignancy
|
LeMense, Gregory P.
|
|
1996
|
15 |
2 |
p. 233-237
5 p.
|
artikel
|
| 74 |
Regulation of differential expression of platelet-derived growth factor α- and β-receptor mRNA in normal and malignant human mesothelial cell lines
|
van der Linden-van Beurden, C.A.J.
|
|
1996
|
15 |
2 |
p. 263-
1 p.
|
artikel
|
| 75 |
Regulation of PDGF chain and receptor expression in malignant mesothelioma
|
Versnel, M.A.
|
|
1996
|
15 |
2 |
p. 264-
1 p.
|
artikel
|
| 76 |
Response rate in single-agent chemotherapy studies from 1960 to 1994 of malignant mesotheliomas
|
Krarup-Hansen, A.
|
|
1996
|
15 |
2 |
p. 275-
1 p.
|
artikel
|
| 77 |
Safety of intrapleural adenoviral gene therapy: Prelude to clinical trial for malignant mesothelioma
|
Sterman, D.
|
|
1996
|
15 |
2 |
p. 278-
1 p.
|
artikel
|
| 78 |
Spontaneous p53 mutation increases sensitivity of murine mesothelial cells to DNA damage induced by asbestos and ionizing radiation
|
Sorger, T.
|
|
1996
|
15 |
2 |
p. 263-
1 p.
|
artikel
|
| 79 |
Surgically debulked malignant pleural mesothelioma: Results and prognostic factors
|
Pass, H.I.
|
|
1996
|
15 |
2 |
p. 277-
1 p.
|
artikel
|
| 80 |
The expression of WT1 in malignant mesothelioma and its utility in the differential diagnosis of pleural-based lesions
|
Amin, K.
|
|
1996
|
15 |
2 |
p. 266-
1 p.
|
artikel
|
| 81 |
The role of mesothelial cells in pleural fibrosis: Effect of asbestos fibres and cytokines on procollagen production in vitro
|
Mutsaers, SE
|
|
1996
|
15 |
2 |
p. 268-
1 p.
|
artikel
|
| 82 |
Treatment and survival in malignant pleural mesothelioma: A study of 83 cases from the Massachusetts General Hospital
|
Huncharek, M.
|
|
1996
|
15 |
2 |
p. 275-
1 p.
|
artikel
|
| 83 |
Treatment of malignant pleural mesothelioma using intrapleural γ-IFN
|
Boutin, C.
|
|
1996
|
15 |
2 |
p. 264-
1 p.
|
artikel
|
| 84 |
Treatment of malignant pleural mesothelioma with methotrexate and interferons-Phase II study
|
Mattson, K.
|
|
1996
|
15 |
2 |
p. 276-
1 p.
|
artikel
|
| 85 |
Treatment of xenograft models of human malignant mesothelioma utilizing adenovirus-mediated gene therapy
|
Smythe, WR
|
|
1996
|
15 |
2 |
p. 278-
1 p.
|
artikel
|
| 86 |
Tremolite, chrysotile and mesothelioma
|
McDonald, JC
|
|
1996
|
15 |
2 |
p. 273-
1 p.
|
artikel
|
| 87 |
Tumor from alost gene: Is there a tumor suppressor gene whose loss is associated with conversion of a mesothelial cell to malignancy?
|
Gerwin, B.I.
|
|
1996
|
15 |
2 |
p. 260-261
2 p.
|
artikel
|
| 88 |
Tumor markers in patients with malignant pleural mesothelioma
|
Togawa, N.
|
|
1996
|
15 |
2 |
p. 269-270
2 p.
|
artikel
|
| 89 |
Tumour-induced immunosuppression and autocrine growth: Use of inducible anti TGF-β antisense RNA transfectants in a mesothelioma model
|
Fitzpatrick, DR
|
|
1996
|
15 |
2 |
p. 260-
1 p.
|
artikel
|
| 90 |
Tumour markers in mesothelioma
|
Baas, P
|
|
1996
|
15 |
2 |
p. 267-
1 p.
|
artikel
|
| 91 |
Two dose levels of ifosfamide in malignant mesothelioma
|
Içli, Fikri
|
|
1996
|
15 |
2 |
p. 207-213
7 p.
|
artikel
|
| 92 |
Unexpected expkession of carbohydrate structures with terminal α-galactosyl residues by mesothelioma cell lines in vitro
|
Pilatte, Y.
|
|
1996
|
15 |
2 |
p. 268-269
2 p.
|
artikel
|
| 93 |
Use of APCR assay for the detection of simian virus 40 genome in human pleural mesothelioma preliminary results
|
Galateau-Sallé, F.
|
|
1996
|
15 |
2 |
p. 260-
1 p.
|
artikel
|
Tijdschrift beschrijving